Joner, M., Finn, A. V., Farb, A., Mont, E. K., Koplodgie, F. D., Ladich, E., . .
. Virmani, R. (n.d.). Pathology of Drug-Eluting Stents in Humans: Delayed
Healing and Late Thrombotic Risk.
This study examined drug eluting stents in Human Clinical trials in
order to determine the long term results of DES implantations on arterial
healing and the development of late stage thrombosis. Comparing the
windows of Thrombotic risk in both Drug eluting and bare metal stents, it
is seen that drug eluting stents represent a longer risk for the
development of arterial complications. Concluding that DES inhibit
arterial healing as compared to bare metal stents, which allow faster
recovery while increasing risk of restinosis, this study further defined
the problems associated with DES in today's medical field.